nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—MAPK1—coronary artery disease	0.281	0.646	CbGaD
Isoprenaline—ADRB3—Timolol—coronary artery disease	0.0925	0.337	CbGbCtD
Isoprenaline—ADRB1—coronary artery disease	0.0836	0.192	CbGaD
Isoprenaline—ADRB2—coronary artery disease	0.0703	0.162	CbGaD
Isoprenaline—ADRB2—Penbutolol—coronary artery disease	0.0537	0.196	CbGbCtD
Isoprenaline—ADRB1—Penbutolol—coronary artery disease	0.0528	0.193	CbGbCtD
Isoprenaline—ADRB2—Timolol—coronary artery disease	0.0378	0.138	CbGbCtD
Isoprenaline—ADRB1—Timolol—coronary artery disease	0.0372	0.136	CbGbCtD
Isoprenaline—PIK3R3—cardiac ventricle—coronary artery disease	0.00299	0.0849	CbGeAlD
Isoprenaline—PIK3R3—myocardium—coronary artery disease	0.00281	0.0798	CbGeAlD
Isoprenaline—PIK3R1—cardiac ventricle—coronary artery disease	0.00256	0.0725	CbGeAlD
Isoprenaline—PIK3R1—myocardium—coronary artery disease	0.0024	0.0682	CbGeAlD
Isoprenaline—PIK3R3—heart—coronary artery disease	0.00196	0.0557	CbGeAlD
Isoprenaline—PIK3R3—cardiovascular system—coronary artery disease	0.00185	0.0526	CbGeAlD
Isoprenaline—MAPK1—cardiac ventricle—coronary artery disease	0.00174	0.0494	CbGeAlD
Isoprenaline—PIK3R1—heart—coronary artery disease	0.00168	0.0476	CbGeAlD
Isoprenaline—ADRBK1—myocardium—coronary artery disease	0.00166	0.0472	CbGeAlD
Isoprenaline—MAPK1—myocardium—coronary artery disease	0.00164	0.0465	CbGeAlD
Isoprenaline—PIK3R1—cardiac atrium—coronary artery disease	0.00144	0.0407	CbGeAlD
Isoprenaline—PIK3R1—blood—coronary artery disease	0.00125	0.0355	CbGeAlD
Isoprenaline—ADRBK1—heart—coronary artery disease	0.00116	0.0329	CbGeAlD
Isoprenaline—MAPK1—heart—coronary artery disease	0.00114	0.0325	CbGeAlD
Isoprenaline—ADRBK1—cardiovascular system—coronary artery disease	0.0011	0.0311	CbGeAlD
Isoprenaline—MAPK1—cardiovascular system—coronary artery disease	0.00108	0.0306	CbGeAlD
Isoprenaline—MAPK1—cardiac atrium—coronary artery disease	0.000979	0.0278	CbGeAlD
Isoprenaline—ADRBK1—blood—coronary artery disease	0.000866	0.0246	CbGeAlD
Isoprenaline—MAPK1—blood—coronary artery disease	0.000854	0.0242	CbGeAlD
Isoprenaline—ADRB1—cardiac ventricle—coronary artery disease	0.00074	0.021	CbGeAlD
Isoprenaline—ADRB1—myocardium—coronary artery disease	0.000696	0.0197	CbGeAlD
Isoprenaline—ADRB1—heart—coronary artery disease	0.000486	0.0138	CbGeAlD
Isoprenaline—CYP1A1—cardiac ventricle—coronary artery disease	0.000477	0.0135	CbGeAlD
Isoprenaline—ADRB1—cardiovascular system—coronary artery disease	0.000458	0.013	CbGeAlD
Isoprenaline—ADRB1—cardiac atrium—coronary artery disease	0.000415	0.0118	CbGeAlD
Isoprenaline—CYP1A1—heart—coronary artery disease	0.000313	0.00888	CbGeAlD
Isoprenaline—CYP1A1—cardiac atrium—coronary artery disease	0.000268	0.0076	CbGeAlD
Isoprenaline—Nervousness—Pravastatin—coronary artery disease	0.000242	0.00301	CcSEcCtD
Isoprenaline—Tachycardia—Fenofibrate—coronary artery disease	0.00024	0.00299	CcSEcCtD
Isoprenaline—Flushing—Perindopril—coronary artery disease	0.000239	0.00298	CcSEcCtD
Isoprenaline—Vision blurred—Niacin—coronary artery disease	0.000238	0.00297	CcSEcCtD
Isoprenaline—Hyperhidrosis—Fenofibrate—coronary artery disease	0.000238	0.00296	CcSEcCtD
Isoprenaline—Headache—Penbutolol—coronary artery disease	0.000237	0.00295	CcSEcCtD
Isoprenaline—Tension—Enalapril—coronary artery disease	0.000236	0.00294	CcSEcCtD
Isoprenaline—Vision blurred—Pravastatin—coronary artery disease	0.000235	0.00292	CcSEcCtD
Isoprenaline—Nervousness—Enalapril—coronary artery disease	0.000234	0.00291	CcSEcCtD
Isoprenaline—CYP1A1—blood—coronary artery disease	0.000234	0.00663	CbGeAlD
Isoprenaline—Vertigo—Valsartan—coronary artery disease	0.000234	0.00291	CcSEcCtD
Isoprenaline—Tremor—Pravastatin—coronary artery disease	0.000233	0.0029	CcSEcCtD
Isoprenaline—Tension—Telmisartan—coronary artery disease	0.000233	0.0029	CcSEcCtD
Isoprenaline—Vertigo—Olmesartan—coronary artery disease	0.000233	0.0029	CcSEcCtD
Isoprenaline—Orciprenaline—ADRB2—coronary artery disease	0.000231	0.0628	CrCbGaD
Isoprenaline—Asthenia—Gemfibrozil—coronary artery disease	0.000231	0.00288	CcSEcCtD
Isoprenaline—Bronchospasm—Lisinopril—coronary artery disease	0.000231	0.00287	CcSEcCtD
Isoprenaline—Nervousness—Telmisartan—coronary artery disease	0.000231	0.00287	CcSEcCtD
Isoprenaline—Arrhythmia—Perindopril—coronary artery disease	0.00023	0.00287	CcSEcCtD
Isoprenaline—Hypotension—Fenofibrate—coronary artery disease	0.00023	0.00286	CcSEcCtD
Isoprenaline—Palpitations—Valsartan—coronary artery disease	0.00023	0.00286	CcSEcCtD
Isoprenaline—Palpitations—Olmesartan—coronary artery disease	0.000229	0.00285	CcSEcCtD
Isoprenaline—Angina pectoris—Lisinopril—coronary artery disease	0.000229	0.00285	CcSEcCtD
Isoprenaline—Vertigo—Niacin—coronary artery disease	0.000227	0.00283	CcSEcCtD
Isoprenaline—Vision blurred—Enalapril—coronary artery disease	0.000227	0.00283	CcSEcCtD
Isoprenaline—Tension—Captopril—coronary artery disease	0.000227	0.00282	CcSEcCtD
Isoprenaline—Hypotension—Clopidogrel—coronary artery disease	0.000226	0.00281	CcSEcCtD
Isoprenaline—Asthenia—Ticagrelor—coronary artery disease	0.000226	0.00281	CcSEcCtD
Isoprenaline—Tremor—Enalapril—coronary artery disease	0.000226	0.00281	CcSEcCtD
Isoprenaline—Nausea—Penbutolol—coronary artery disease	0.000225	0.00279	CcSEcCtD
Isoprenaline—Nervousness—Captopril—coronary artery disease	0.000224	0.00279	CcSEcCtD
Isoprenaline—Flushing—Losartan—coronary artery disease	0.000224	0.00279	CcSEcCtD
Isoprenaline—Arrhythmia—Furosemide—coronary artery disease	0.000224	0.00279	CcSEcCtD
Isoprenaline—Vertigo—Pravastatin—coronary artery disease	0.000224	0.00278	CcSEcCtD
Isoprenaline—Palpitations—Niacin—coronary artery disease	0.000224	0.00278	CcSEcCtD
Isoprenaline—Hyperhidrosis—Eplerenone—coronary artery disease	0.000223	0.00278	CcSEcCtD
Isoprenaline—Insomnia—Fenofibrate—coronary artery disease	0.000223	0.00277	CcSEcCtD
Isoprenaline—Sweating—Ramipril—coronary artery disease	0.000221	0.00275	CcSEcCtD
Isoprenaline—Tension—Perindopril—coronary artery disease	0.00022	0.00274	CcSEcCtD
Isoprenaline—Dyspnoea—Fenofibrate—coronary artery disease	0.000219	0.00273	CcSEcCtD
Isoprenaline—Insomnia—Clopidogrel—coronary artery disease	0.000219	0.00272	CcSEcCtD
Isoprenaline—Nervousness—Perindopril—coronary artery disease	0.000218	0.00271	CcSEcCtD
Isoprenaline—Vision blurred—Captopril—coronary artery disease	0.000218	0.00271	CcSEcCtD
Isoprenaline—Insomnia—Lovastatin—coronary artery disease	0.000217	0.00271	CcSEcCtD
Isoprenaline—Vertigo—Trandolapril—coronary artery disease	0.000217	0.0027	CcSEcCtD
Isoprenaline—Vertigo—Enalapril—coronary artery disease	0.000216	0.00269	CcSEcCtD
Isoprenaline—Sweating—Timolol—coronary artery disease	0.000216	0.00269	CcSEcCtD
Isoprenaline—Arrhythmia—Losartan—coronary artery disease	0.000216	0.00269	CcSEcCtD
Isoprenaline—Dyspnoea—Clopidogrel—coronary artery disease	0.000216	0.00268	CcSEcCtD
Isoprenaline—Hypotension—Eplerenone—coronary artery disease	0.000216	0.00268	CcSEcCtD
Isoprenaline—Hypertension—Pravastatin—coronary artery disease	0.000215	0.00268	CcSEcCtD
Isoprenaline—Dyspnoea—Lovastatin—coronary artery disease	0.000214	0.00267	CcSEcCtD
Isoprenaline—Palpitations—Trandolapril—coronary artery disease	0.000214	0.00266	CcSEcCtD
Isoprenaline—Vertigo—Telmisartan—coronary artery disease	0.000213	0.00266	CcSEcCtD
Isoprenaline—Dizziness—Gemfibrozil—coronary artery disease	0.000213	0.00265	CcSEcCtD
Isoprenaline—Insomnia—Ezetimibe—coronary artery disease	0.000213	0.00265	CcSEcCtD
Isoprenaline—Palpitations—Enalapril—coronary artery disease	0.000213	0.00265	CcSEcCtD
Isoprenaline—Dyspnoea—Ezetimibe—coronary artery disease	0.00021	0.00262	CcSEcCtD
Isoprenaline—Tremor—Perindopril—coronary artery disease	0.00021	0.00262	CcSEcCtD
Isoprenaline—Palpitations—Telmisartan—coronary artery disease	0.00021	0.00261	CcSEcCtD
Isoprenaline—Insomnia—Eplerenone—coronary artery disease	0.000209	0.0026	CcSEcCtD
Isoprenaline—Dizziness—Ticagrelor—coronary artery disease	0.000208	0.00259	CcSEcCtD
Isoprenaline—Tension—Losartan—coronary artery disease	0.000206	0.00257	CcSEcCtD
Isoprenaline—Tachycardia—Olmesartan—coronary artery disease	0.000206	0.00257	CcSEcCtD
Isoprenaline—Dyspnoea—Eplerenone—coronary artery disease	0.000206	0.00256	CcSEcCtD
Isoprenaline—Vision blurred—Furosemide—coronary artery disease	0.000205	0.00256	CcSEcCtD
Isoprenaline—Hypertension—Telmisartan—coronary artery disease	0.000205	0.00255	CcSEcCtD
Isoprenaline—Nervousness—Losartan—coronary artery disease	0.000204	0.00254	CcSEcCtD
Isoprenaline—Hyperhidrosis—Olmesartan—coronary artery disease	0.000204	0.00254	CcSEcCtD
Isoprenaline—Palpitations—Captopril—coronary artery disease	0.000204	0.00254	CcSEcCtD
Isoprenaline—Asthenia—Rosuvastatin—coronary artery disease	0.000203	0.00253	CcSEcCtD
Isoprenaline—Insomnia—Simvastatin—coronary artery disease	0.000203	0.00253	CcSEcCtD
Isoprenaline—Headache—Gemfibrozil—coronary artery disease	0.000202	0.00252	CcSEcCtD
Isoprenaline—Vertigo—Perindopril—coronary artery disease	0.000202	0.00251	CcSEcCtD
Isoprenaline—Tachycardia—Niacin—coronary artery disease	0.000201	0.00251	CcSEcCtD
Isoprenaline—Sweating—Lisinopril—coronary artery disease	0.000201	0.0025	CcSEcCtD
Isoprenaline—Dyspnoea—Simvastatin—coronary artery disease	0.0002	0.00249	CcSEcCtD
Isoprenaline—Hyperhidrosis—Niacin—coronary artery disease	0.0002	0.00248	CcSEcCtD
Isoprenaline—Hypotension—Valsartan—coronary artery disease	0.000198	0.00247	CcSEcCtD
Isoprenaline—Vision blurred—Losartan—coronary artery disease	0.000198	0.00247	CcSEcCtD
Isoprenaline—Palpitations—Perindopril—coronary artery disease	0.000198	0.00247	CcSEcCtD
Isoprenaline—Hypotension—Olmesartan—coronary artery disease	0.000197	0.00246	CcSEcCtD
Isoprenaline—Headache—Ticagrelor—coronary artery disease	0.000197	0.00246	CcSEcCtD
Isoprenaline—Tremor—Losartan—coronary artery disease	0.000197	0.00245	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pravastatin—coronary artery disease	0.000196	0.00245	CcSEcCtD
Isoprenaline—Vertigo—Furosemide—coronary artery disease	0.000196	0.00244	CcSEcCtD
Isoprenaline—Hypertension—Perindopril—coronary artery disease	0.000194	0.00241	CcSEcCtD
Isoprenaline—Hypotension—Niacin—coronary artery disease	0.000193	0.0024	CcSEcCtD
Isoprenaline—Tachycardia—Trandolapril—coronary artery disease	0.000193	0.0024	CcSEcCtD
Isoprenaline—Flushing—Ramipril—coronary artery disease	0.000192	0.00239	CcSEcCtD
Isoprenaline—Insomnia—Valsartan—coronary artery disease	0.000192	0.00239	CcSEcCtD
Isoprenaline—Tachycardia—Enalapril—coronary artery disease	0.000192	0.00239	CcSEcCtD
Isoprenaline—Nausea—Gemfibrozil—coronary artery disease	0.000192	0.00238	CcSEcCtD
Isoprenaline—Insomnia—Olmesartan—coronary artery disease	0.000191	0.00238	CcSEcCtD
Isoprenaline—Hyperhidrosis—Trandolapril—coronary artery disease	0.000191	0.00237	CcSEcCtD
Isoprenaline—Hyperhidrosis—Enalapril—coronary artery disease	0.00019	0.00237	CcSEcCtD
Isoprenaline—Dyspnoea—Valsartan—coronary artery disease	0.000189	0.00236	CcSEcCtD
Isoprenaline—Tachycardia—Telmisartan—coronary artery disease	0.000189	0.00236	CcSEcCtD
Isoprenaline—Vertigo—Losartan—coronary artery disease	0.000189	0.00235	CcSEcCtD
Isoprenaline—Dizziness—Rosuvastatin—coronary artery disease	0.000188	0.00233	CcSEcCtD
Isoprenaline—Hyperhidrosis—Telmisartan—coronary artery disease	0.000187	0.00233	CcSEcCtD
Isoprenaline—Nausea—Ticagrelor—coronary artery disease	0.000187	0.00233	CcSEcCtD
Isoprenaline—Insomnia—Niacin—coronary artery disease	0.000187	0.00232	CcSEcCtD
Isoprenaline—Palpitations—Losartan—coronary artery disease	0.000186	0.00231	CcSEcCtD
Isoprenaline—Arrhythmia—Ramipril—coronary artery disease	0.000185	0.0023	CcSEcCtD
Isoprenaline—Hypotension—Trandolapril—coronary artery disease	0.000184	0.0023	CcSEcCtD
Isoprenaline—Dyspnoea—Niacin—coronary artery disease	0.000184	0.00229	CcSEcCtD
Isoprenaline—Tachycardia—Captopril—coronary artery disease	0.000184	0.00229	CcSEcCtD
Isoprenaline—Insomnia—Pravastatin—coronary artery disease	0.000184	0.00229	CcSEcCtD
Isoprenaline—Hypotension—Enalapril—coronary artery disease	0.000184	0.00229	CcSEcCtD
Isoprenaline—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000182	0.00227	CcSEcCtD
Isoprenaline—Dyspnoea—Pravastatin—coronary artery disease	0.000181	0.00226	CcSEcCtD
Isoprenaline—Hypotension—Telmisartan—coronary artery disease	0.000181	0.00226	CcSEcCtD
Isoprenaline—Arrhythmia—Timolol—coronary artery disease	0.000181	0.00225	CcSEcCtD
Isoprenaline—Tachycardia—Perindopril—coronary artery disease	0.000179	0.00222	CcSEcCtD
Isoprenaline—Insomnia—Trandolapril—coronary artery disease	0.000179	0.00222	CcSEcCtD
Isoprenaline—Insomnia—Enalapril—coronary artery disease	0.000178	0.00221	CcSEcCtD
Isoprenaline—Headache—Rosuvastatin—coronary artery disease	0.000178	0.00221	CcSEcCtD
Isoprenaline—Tension—Ramipril—coronary artery disease	0.000177	0.0022	CcSEcCtD
Isoprenaline—Hyperhidrosis—Perindopril—coronary artery disease	0.000177	0.0022	CcSEcCtD
Isoprenaline—Asthenia—Fenofibrate—coronary artery disease	0.000177	0.0022	CcSEcCtD
Isoprenaline—Hypotension—Captopril—coronary artery disease	0.000176	0.00219	CcSEcCtD
Isoprenaline—Dyspnoea—Trandolapril—coronary artery disease	0.000176	0.00219	CcSEcCtD
Isoprenaline—Insomnia—Telmisartan—coronary artery disease	0.000175	0.00218	CcSEcCtD
Isoprenaline—Dyspnoea—Enalapril—coronary artery disease	0.000175	0.00218	CcSEcCtD
Isoprenaline—Nervousness—Ramipril—coronary artery disease	0.000175	0.00218	CcSEcCtD
Isoprenaline—Flushing—Lisinopril—coronary artery disease	0.000174	0.00217	CcSEcCtD
Isoprenaline—Isoetarine—ADRB1—coronary artery disease	0.000174	0.0472	CrCbGaD
Isoprenaline—Asthenia—Clopidogrel—coronary artery disease	0.000174	0.00216	CcSEcCtD
Isoprenaline—Tension—Timolol—coronary artery disease	0.000173	0.00215	CcSEcCtD
Isoprenaline—Dyspnoea—Telmisartan—coronary artery disease	0.000173	0.00215	CcSEcCtD
Isoprenaline—Asthenia—Lovastatin—coronary artery disease	0.000172	0.00215	CcSEcCtD
Isoprenaline—Hyperhidrosis—Furosemide—coronary artery disease	0.000172	0.00214	CcSEcCtD
Isoprenaline—Nervousness—Timolol—coronary artery disease	0.000171	0.00213	CcSEcCtD
Isoprenaline—Hypotension—Perindopril—coronary artery disease	0.000171	0.00213	CcSEcCtD
Isoprenaline—Insomnia—Captopril—coronary artery disease	0.000171	0.00212	CcSEcCtD
Isoprenaline—Asthenia—Ezetimibe—coronary artery disease	0.000169	0.00211	CcSEcCtD
Isoprenaline—Tremor—Ramipril—coronary artery disease	0.000169	0.0021	CcSEcCtD
Isoprenaline—Nausea—Rosuvastatin—coronary artery disease	0.000168	0.0021	CcSEcCtD
Isoprenaline—Sotalol—ADRB1—coronary artery disease	0.000168	0.0456	CrCbGaD
Isoprenaline—Dyspnoea—Captopril—coronary artery disease	0.000168	0.00209	CcSEcCtD
Isoprenaline—Arrhythmia—Lisinopril—coronary artery disease	0.000168	0.00209	CcSEcCtD
Isoprenaline—Tachycardia—Losartan—coronary artery disease	0.000168	0.00209	CcSEcCtD
Isoprenaline—Hypotension—Furosemide—coronary artery disease	0.000166	0.00207	CcSEcCtD
Isoprenaline—Vision blurred—Timolol—coronary artery disease	0.000166	0.00207	CcSEcCtD
Isoprenaline—Hyperhidrosis—Losartan—coronary artery disease	0.000166	0.00207	CcSEcCtD
Isoprenaline—Insomnia—Perindopril—coronary artery disease	0.000166	0.00206	CcSEcCtD
Isoprenaline—Asthenia—Eplerenone—coronary artery disease	0.000166	0.00206	CcSEcCtD
Isoprenaline—Nausea—Acetylsalicylic acid—coronary artery disease	0.000164	0.00204	CcSEcCtD
Isoprenaline—Dyspnoea—Perindopril—coronary artery disease	0.000163	0.00203	CcSEcCtD
Isoprenaline—Dizziness—Fenofibrate—coronary artery disease	0.000163	0.00203	CcSEcCtD
Isoprenaline—Vertigo—Ramipril—coronary artery disease	0.000162	0.00202	CcSEcCtD
Isoprenaline—Asthenia—Simvastatin—coronary artery disease	0.000161	0.00201	CcSEcCtD
Isoprenaline—Tension—Lisinopril—coronary artery disease	0.000161	0.002	CcSEcCtD
Isoprenaline—Hypotension—Losartan—coronary artery disease	0.00016	0.002	CcSEcCtD
Isoprenaline—Dizziness—Clopidogrel—coronary artery disease	0.00016	0.00199	CcSEcCtD
Isoprenaline—Palpitations—Ramipril—coronary artery disease	0.000159	0.00198	CcSEcCtD
Isoprenaline—Dizziness—Lovastatin—coronary artery disease	0.000159	0.00198	CcSEcCtD
Isoprenaline—Nervousness—Lisinopril—coronary artery disease	0.000159	0.00198	CcSEcCtD
Isoprenaline—Vertigo—Timolol—coronary artery disease	0.000158	0.00197	CcSEcCtD
Isoprenaline—Convulsion—Ramipril—coronary artery disease	0.000156	0.00195	CcSEcCtD
Isoprenaline—Dizziness—Ezetimibe—coronary artery disease	0.000156	0.00194	CcSEcCtD
Isoprenaline—Palpitations—Timolol—coronary artery disease	0.000156	0.00194	CcSEcCtD
Isoprenaline—Insomnia—Losartan—coronary artery disease	0.000155	0.00193	CcSEcCtD
Isoprenaline—Headache—Fenofibrate—coronary artery disease	0.000154	0.00192	CcSEcCtD
Isoprenaline—Vision blurred—Lisinopril—coronary artery disease	0.000154	0.00192	CcSEcCtD
Isoprenaline—Tremor—Lisinopril—coronary artery disease	0.000153	0.00191	CcSEcCtD
Isoprenaline—Dyspnoea—Losartan—coronary artery disease	0.000153	0.00191	CcSEcCtD
Isoprenaline—Dizziness—Eplerenone—coronary artery disease	0.000153	0.0019	CcSEcCtD
Isoprenaline—Asthenia—Valsartan—coronary artery disease	0.000152	0.0019	CcSEcCtD
Isoprenaline—Hypertension—Timolol—coronary artery disease	0.000152	0.0019	CcSEcCtD
Isoprenaline—Terbutaline—ADRB2—coronary artery disease	0.000152	0.0412	CrCbGaD
Isoprenaline—Asthenia—Olmesartan—coronary artery disease	0.000152	0.00189	CcSEcCtD
Isoprenaline—Headache—Clopidogrel—coronary artery disease	0.000152	0.00189	CcSEcCtD
Isoprenaline—Headache—Lovastatin—coronary artery disease	0.000151	0.00187	CcSEcCtD
Isoprenaline—Dizziness—Simvastatin—coronary artery disease	0.000149	0.00185	CcSEcCtD
Isoprenaline—Asthenia—Niacin—coronary artery disease	0.000148	0.00184	CcSEcCtD
Isoprenaline—Fenoterol—ADRB1—coronary artery disease	0.000148	0.0401	CrCbGaD
Isoprenaline—Headache—Ezetimibe—coronary artery disease	0.000148	0.00184	CcSEcCtD
Isoprenaline—Vertigo—Lisinopril—coronary artery disease	0.000147	0.00183	CcSEcCtD
Isoprenaline—Isoetarine—ADRB2—coronary artery disease	0.000146	0.0397	CrCbGaD
Isoprenaline—Nausea—Fenofibrate—coronary artery disease	0.000146	0.00182	CcSEcCtD
Isoprenaline—Asthenia—Pravastatin—coronary artery disease	0.000146	0.00182	CcSEcCtD
Isoprenaline—Palpitations—Lisinopril—coronary artery disease	0.000145	0.0018	CcSEcCtD
Isoprenaline—Headache—Eplerenone—coronary artery disease	0.000145	0.0018	CcSEcCtD
Isoprenaline—Nausea—Clopidogrel—coronary artery disease	0.000144	0.00179	CcSEcCtD
Isoprenaline—Tachycardia—Ramipril—coronary artery disease	0.000144	0.00179	CcSEcCtD
Isoprenaline—Nausea—Lovastatin—coronary artery disease	0.000143	0.00178	CcSEcCtD
Isoprenaline—Hyperhidrosis—Ramipril—coronary artery disease	0.000142	0.00177	CcSEcCtD
Isoprenaline—Asthenia—Trandolapril—coronary artery disease	0.000142	0.00176	CcSEcCtD
Isoprenaline—Sotalol—ADRB2—coronary artery disease	0.000141	0.0383	CrCbGaD
Isoprenaline—Asthenia—Enalapril—coronary artery disease	0.000141	0.00176	CcSEcCtD
Isoprenaline—Headache—Simvastatin—coronary artery disease	0.000141	0.00175	CcSEcCtD
Isoprenaline—Dizziness—Valsartan—coronary artery disease	0.00014	0.00175	CcSEcCtD
Isoprenaline—Nausea—Ezetimibe—coronary artery disease	0.00014	0.00174	CcSEcCtD
Isoprenaline—Dizziness—Olmesartan—coronary artery disease	0.00014	0.00174	CcSEcCtD
Isoprenaline—Hyperhidrosis—Timolol—coronary artery disease	0.000139	0.00173	CcSEcCtD
Isoprenaline—Asthenia—Telmisartan—coronary artery disease	0.000139	0.00173	CcSEcCtD
Isoprenaline—Arbutamine—ADRB1—coronary artery disease	0.000138	0.0375	CrCbGaD
Isoprenaline—Hypotension—Ramipril—coronary artery disease	0.000138	0.00171	CcSEcCtD
Isoprenaline—Nausea—Eplerenone—coronary artery disease	0.000137	0.00171	CcSEcCtD
Isoprenaline—Dizziness—Niacin—coronary artery disease	0.000136	0.0017	CcSEcCtD
Isoprenaline—Asthenia—Captopril—coronary artery disease	0.000135	0.00168	CcSEcCtD
Isoprenaline—Hypotension—Timolol—coronary artery disease	0.000134	0.00167	CcSEcCtD
Isoprenaline—Salbutamol—ADRB1—coronary artery disease	0.000134	0.0364	CrCbGaD
Isoprenaline—Formoterol—ADRB1—coronary artery disease	0.000134	0.0364	CrCbGaD
Isoprenaline—Arformoterol—ADRB1—coronary artery disease	0.000134	0.0364	CrCbGaD
Isoprenaline—Dizziness—Pravastatin—coronary artery disease	0.000134	0.00167	CcSEcCtD
Isoprenaline—Nausea—Simvastatin—coronary artery disease	0.000134	0.00166	CcSEcCtD
Isoprenaline—Insomnia—Ramipril—coronary artery disease	0.000133	0.00166	CcSEcCtD
Isoprenaline—Headache—Valsartan—coronary artery disease	0.000133	0.00166	CcSEcCtD
Isoprenaline—Headache—Olmesartan—coronary artery disease	0.000132	0.00165	CcSEcCtD
Isoprenaline—Asthenia—Perindopril—coronary artery disease	0.000131	0.00163	CcSEcCtD
Isoprenaline—Dyspnoea—Ramipril—coronary artery disease	0.000131	0.00163	CcSEcCtD
Isoprenaline—Dizziness—Trandolapril—coronary artery disease	0.000131	0.00162	CcSEcCtD
Isoprenaline—Tachycardia—Lisinopril—coronary artery disease	0.00013	0.00162	CcSEcCtD
Isoprenaline—Insomnia—Timolol—coronary artery disease	0.00013	0.00162	CcSEcCtD
Isoprenaline—Dizziness—Enalapril—coronary artery disease	0.00013	0.00162	CcSEcCtD
Isoprenaline—Headache—Niacin—coronary artery disease	0.000129	0.00161	CcSEcCtD
Isoprenaline—Hyperhidrosis—Lisinopril—coronary artery disease	0.000129	0.00161	CcSEcCtD
Isoprenaline—Dyspnoea—Timolol—coronary artery disease	0.000128	0.0016	CcSEcCtD
Isoprenaline—Dizziness—Telmisartan—coronary artery disease	0.000128	0.0016	CcSEcCtD
Isoprenaline—Asthenia—Furosemide—coronary artery disease	0.000128	0.00159	CcSEcCtD
Isoprenaline—Headache—Pravastatin—coronary artery disease	0.000127	0.00158	CcSEcCtD
Isoprenaline—Nausea—Valsartan—coronary artery disease	0.000126	0.00157	CcSEcCtD
Isoprenaline—Nausea—Olmesartan—coronary artery disease	0.000125	0.00156	CcSEcCtD
Isoprenaline—Hypotension—Lisinopril—coronary artery disease	0.000125	0.00155	CcSEcCtD
Isoprenaline—Dizziness—Captopril—coronary artery disease	0.000125	0.00155	CcSEcCtD
Isoprenaline—Fenoterol—ADRB2—coronary artery disease	0.000124	0.0338	CrCbGaD
Isoprenaline—Headache—Trandolapril—coronary artery disease	0.000124	0.00154	CcSEcCtD
Isoprenaline—Asthenia—Losartan—coronary artery disease	0.000123	0.00153	CcSEcCtD
Isoprenaline—Headache—Enalapril—coronary artery disease	0.000123	0.00153	CcSEcCtD
Isoprenaline—Norepinephrine—SLC22A3—coronary artery disease	0.000123	0.0334	CrCbGaD
Isoprenaline—Nausea—Niacin—coronary artery disease	0.000123	0.00153	CcSEcCtD
Isoprenaline—Headache—Telmisartan—coronary artery disease	0.000121	0.00151	CcSEcCtD
Isoprenaline—Dizziness—Perindopril—coronary artery disease	0.000121	0.00151	CcSEcCtD
Isoprenaline—Insomnia—Lisinopril—coronary artery disease	0.000121	0.0015	CcSEcCtD
Isoprenaline—Nausea—Pravastatin—coronary artery disease	0.000121	0.0015	CcSEcCtD
Isoprenaline—Dyspnoea—Lisinopril—coronary artery disease	0.000119	0.00148	CcSEcCtD
Isoprenaline—Headache—Captopril—coronary artery disease	0.000118	0.00147	CcSEcCtD
Isoprenaline—Dizziness—Furosemide—coronary artery disease	0.000118	0.00146	CcSEcCtD
Isoprenaline—Nausea—Trandolapril—coronary artery disease	0.000117	0.00146	CcSEcCtD
Isoprenaline—Nausea—Enalapril—coronary artery disease	0.000117	0.00145	CcSEcCtD
Isoprenaline—Arbutamine—ADRB2—coronary artery disease	0.000116	0.0316	CrCbGaD
Isoprenaline—Nausea—Telmisartan—coronary artery disease	0.000115	0.00143	CcSEcCtD
Isoprenaline—Headache—Perindopril—coronary artery disease	0.000115	0.00143	CcSEcCtD
Isoprenaline—Dopamine—SLC22A3—coronary artery disease	0.000114	0.031	CrCbGaD
Isoprenaline—Dizziness—Losartan—coronary artery disease	0.000114	0.00141	CcSEcCtD
Isoprenaline—Arformoterol—ADRB2—coronary artery disease	0.000113	0.0306	CrCbGaD
Isoprenaline—Formoterol—ADRB2—coronary artery disease	0.000113	0.0306	CrCbGaD
Isoprenaline—Salbutamol—ADRB2—coronary artery disease	0.000113	0.0306	CrCbGaD
Isoprenaline—Nausea—Captopril—coronary artery disease	0.000112	0.00139	CcSEcCtD
Isoprenaline—Headache—Furosemide—coronary artery disease	0.000111	0.00139	CcSEcCtD
Isoprenaline—Nausea—Perindopril—coronary artery disease	0.000109	0.00135	CcSEcCtD
Isoprenaline—Headache—Losartan—coronary artery disease	0.000108	0.00134	CcSEcCtD
Isoprenaline—Nausea—Furosemide—coronary artery disease	0.000106	0.00132	CcSEcCtD
Isoprenaline—Asthenia—Ramipril—coronary artery disease	0.000106	0.00131	CcSEcCtD
Isoprenaline—Asthenia—Timolol—coronary artery disease	0.000103	0.00129	CcSEcCtD
Isoprenaline—Nausea—Losartan—coronary artery disease	0.000102	0.00127	CcSEcCtD
Isoprenaline—Labetalol—ADRB1—coronary artery disease	9.82e-05	0.0266	CrCbGaD
Isoprenaline—Dizziness—Ramipril—coronary artery disease	9.74e-05	0.00121	CcSEcCtD
Isoprenaline—Formoterol—CYP2C19—coronary artery disease	9.73e-05	0.0264	CrCbGaD
Isoprenaline—Arformoterol—CYP2C19—coronary artery disease	9.73e-05	0.0264	CrCbGaD
Isoprenaline—Asthenia—Lisinopril—coronary artery disease	9.58e-05	0.00119	CcSEcCtD
Isoprenaline—Dizziness—Timolol—coronary artery disease	9.52e-05	0.00118	CcSEcCtD
Isoprenaline—Pindolol—ADRB1—coronary artery disease	9.43e-05	0.0256	CrCbGaD
Isoprenaline—Headache—Ramipril—coronary artery disease	9.22e-05	0.00115	CcSEcCtD
Isoprenaline—Headache—Timolol—coronary artery disease	9.02e-05	0.00112	CcSEcCtD
Isoprenaline—Dizziness—Lisinopril—coronary artery disease	8.83e-05	0.0011	CcSEcCtD
Isoprenaline—Nausea—Ramipril—coronary artery disease	8.74e-05	0.00109	CcSEcCtD
Isoprenaline—Nausea—Timolol—coronary artery disease	8.55e-05	0.00106	CcSEcCtD
Isoprenaline—Headache—Lisinopril—coronary artery disease	8.36e-05	0.00104	CcSEcCtD
Isoprenaline—Labetalol—ADRB2—coronary artery disease	8.26e-05	0.0224	CrCbGaD
Isoprenaline—Droxidopa—ADRB1—coronary artery disease	7.95e-05	0.0216	CrCbGaD
Isoprenaline—Nausea—Lisinopril—coronary artery disease	7.93e-05	0.000987	CcSEcCtD
Isoprenaline—Pindolol—ADRB2—coronary artery disease	7.93e-05	0.0215	CrCbGaD
Isoprenaline—Dopamine—HTR7—coronary artery disease	7.26e-05	0.0197	CrCbGaD
Isoprenaline—Norepinephrine—ADRB1—coronary artery disease	6.69e-05	0.0181	CrCbGaD
Isoprenaline—Droxidopa—ADRB2—coronary artery disease	6.69e-05	0.0181	CrCbGaD
Isoprenaline—Dopamine—ADRB1—coronary artery disease	6.22e-05	0.0169	CrCbGaD
Isoprenaline—Epinephrine—ADRB1—coronary artery disease	6.07e-05	0.0165	CrCbGaD
Isoprenaline—Epinephrine—TNF—coronary artery disease	5.76e-05	0.0156	CrCbGaD
Isoprenaline—Norepinephrine—ADRB2—coronary artery disease	5.63e-05	0.0153	CrCbGaD
Isoprenaline—Epinephrine—ADRB2—coronary artery disease	5.11e-05	0.0138	CrCbGaD
Isoprenaline—Dopamine—CYP2C19—coronary artery disease	4.51e-05	0.0122	CrCbGaD
Isoprenaline—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	1.17e-06	6.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—PIK3CA—coronary artery disease	1.17e-06	6.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—coronary artery disease	1.16e-06	6.76e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—coronary artery disease	1.16e-06	6.76e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—JAK2—coronary artery disease	1.16e-06	6.74e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—coronary artery disease	1.16e-06	6.72e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOB—coronary artery disease	1.16e-06	6.72e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—coronary artery disease	1.16e-06	6.71e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLCB1—coronary artery disease	1.16e-06	6.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—coronary artery disease	1.15e-06	6.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—JAK2—coronary artery disease	1.15e-06	6.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—coronary artery disease	1.15e-06	6.68e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	1.15e-06	6.66e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—coronary artery disease	1.15e-06	6.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	1.14e-06	6.63e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—coronary artery disease	1.14e-06	6.61e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PIK3CA—coronary artery disease	1.14e-06	6.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HIF1A—coronary artery disease	1.14e-06	6.61e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CSF2—coronary artery disease	1.14e-06	6.61e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGF1—coronary artery disease	1.14e-06	6.61e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.13e-06	6.58e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AGT—coronary artery disease	1.13e-06	6.58e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MAPK1—coronary artery disease	1.13e-06	6.58e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—coronary artery disease	1.13e-06	6.56e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LPL—coronary artery disease	1.13e-06	6.56e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—coronary artery disease	1.13e-06	6.55e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCA1—coronary artery disease	1.12e-06	6.5e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	1.12e-06	6.5e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	1.12e-06	6.5e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CSF2—coronary artery disease	1.11e-06	6.46e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGF1—coronary artery disease	1.11e-06	6.46e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—coronary artery disease	1.11e-06	6.45e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—coronary artery disease	1.11e-06	6.45e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LPL—coronary artery disease	1.1e-06	6.41e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—coronary artery disease	1.1e-06	6.39e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOA1—coronary artery disease	1.1e-06	6.37e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—coronary artery disease	1.09e-06	6.36e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	1.09e-06	6.36e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	1.09e-06	6.36e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	1.09e-06	6.33e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—coronary artery disease	1.09e-06	6.32e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KDR—coronary artery disease	1.09e-06	6.32e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—coronary artery disease	1.09e-06	6.31e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—coronary artery disease	1.09e-06	6.3e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GGT1—coronary artery disease	1.08e-06	6.3e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GOT1—coronary artery disease	1.08e-06	6.3e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK14—coronary artery disease	1.08e-06	6.28e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—coronary artery disease	1.07e-06	6.24e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—coronary artery disease	1.07e-06	6.24e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—coronary artery disease	1.07e-06	6.23e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	1.07e-06	6.19e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PIK3CA—coronary artery disease	1.07e-06	6.19e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—PIK3CA—coronary artery disease	1.06e-06	6.19e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	1.06e-06	6.18e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ESR1—coronary artery disease	1.06e-06	6.16e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—coronary artery disease	1.06e-06	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	1.06e-06	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—coronary artery disease	1.06e-06	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—coronary artery disease	1.06e-06	6.14e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—coronary artery disease	1.05e-06	6.09e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—F2—coronary artery disease	1.05e-06	6.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FN1—coronary artery disease	1.05e-06	6.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6ST—coronary artery disease	1.04e-06	6.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—coronary artery disease	1.04e-06	6.05e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	1.04e-06	6.05e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	1.04e-06	6.04e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—coronary artery disease	1.04e-06	6.03e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	1.04e-06	6.02e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKBIA—coronary artery disease	1.03e-06	6.01e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—coronary artery disease	1.03e-06	6e-06	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—coronary artery disease	1.02e-06	5.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	1.02e-06	5.91e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	1.02e-06	5.91e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—coronary artery disease	1.02e-06	5.9e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PIK3CA—coronary artery disease	1.02e-06	5.9e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—coronary artery disease	1.02e-06	5.9e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—coronary artery disease	1.01e-06	5.89e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCND1—coronary artery disease	1.01e-06	5.87e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—coronary artery disease	1.01e-06	5.85e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KIT—coronary artery disease	1e-06	5.82e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—coronary artery disease	9.99e-07	5.8e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	9.96e-07	5.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—coronary artery disease	9.94e-07	5.78e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—coronary artery disease	9.91e-07	5.76e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCND1—coronary artery disease	9.87e-07	5.73e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—coronary artery disease	9.84e-07	5.71e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PIK3CA—coronary artery disease	9.83e-07	5.71e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—coronary artery disease	9.82e-07	5.7e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK1—coronary artery disease	9.79e-07	5.69e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—coronary artery disease	9.76e-07	5.67e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTP1—coronary artery disease	9.74e-07	5.66e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	9.69e-07	5.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AGT—coronary artery disease	9.66e-07	5.61e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	9.65e-07	5.61e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK1—coronary artery disease	9.65e-07	5.6e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GSK3B—coronary artery disease	9.61e-07	5.58e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—coronary artery disease	9.61e-07	5.58e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—coronary artery disease	9.58e-07	5.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—coronary artery disease	9.54e-07	5.54e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CREB1—coronary artery disease	9.54e-07	5.54e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—coronary artery disease	9.52e-07	5.53e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	9.48e-07	5.51e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAT—coronary artery disease	9.48e-07	5.51e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—coronary artery disease	9.46e-07	5.5e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—coronary artery disease	9.46e-07	5.5e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGT—coronary artery disease	9.45e-07	5.49e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—coronary artery disease	9.44e-07	5.48e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—coronary artery disease	9.43e-07	5.48e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOA1—coronary artery disease	9.35e-07	5.43e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—coronary artery disease	9.33e-07	5.42e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6R—coronary artery disease	9.3e-07	5.4e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—coronary artery disease	9.29e-07	5.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KDR—coronary artery disease	9.27e-07	5.38e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—coronary artery disease	9.26e-07	5.38e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—coronary artery disease	9.26e-07	5.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	9.21e-07	5.35e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOB—coronary artery disease	9.2e-07	5.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—coronary artery disease	9.17e-07	5.33e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOA1—coronary artery disease	9.15e-07	5.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KDR—coronary artery disease	9.07e-07	5.27e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—coronary artery disease	9.03e-07	5.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	9.01e-07	5.23e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—coronary artery disease	8.95e-07	5.2e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—F2—coronary artery disease	8.92e-07	5.18e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FN1—coronary artery disease	8.92e-07	5.18e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	8.89e-07	5.16e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—coronary artery disease	8.84e-07	5.13e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	8.82e-07	5.12e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—coronary artery disease	8.82e-07	5.12e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—LPL—coronary artery disease	8.79e-07	5.1e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—F2—coronary artery disease	8.73e-07	5.07e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FN1—coronary artery disease	8.73e-07	5.07e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—coronary artery disease	8.71e-07	5.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—coronary artery disease	8.71e-07	5.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—coronary artery disease	8.71e-07	5.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—coronary artery disease	8.7e-07	5.05e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	8.69e-07	5.05e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	8.62e-07	5.01e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—coronary artery disease	8.6e-07	5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—coronary artery disease	8.57e-07	4.98e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—coronary artery disease	8.54e-07	4.96e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PIK3CA—coronary artery disease	8.5e-07	4.94e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FGF2—coronary artery disease	8.43e-07	4.9e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PIK3CA—coronary artery disease	8.37e-07	4.86e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—coronary artery disease	8.35e-07	4.85e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CD36—coronary artery disease	8.35e-07	4.85e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—coronary artery disease	8.32e-07	4.83e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—coronary artery disease	8.3e-07	4.82e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPP2CA—coronary artery disease	8.24e-07	4.79e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PIK3CA—coronary artery disease	8.23e-07	4.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	8.19e-07	4.76e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—coronary artery disease	8.13e-07	4.72e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CREB1—coronary artery disease	8.13e-07	4.72e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—coronary artery disease	8.09e-07	4.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JAK2—coronary artery disease	8.08e-07	4.7e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—coronary artery disease	8.03e-07	4.67e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	8.02e-07	4.66e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—coronary artery disease	7.95e-07	4.62e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—coronary artery disease	7.95e-07	4.62e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CREB1—coronary artery disease	7.95e-07	4.62e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK1—coronary artery disease	7.93e-07	4.61e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6R—coronary artery disease	7.93e-07	4.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PIK3CA—coronary artery disease	7.92e-07	4.6e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—coronary artery disease	7.91e-07	4.6e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	7.9e-07	4.59e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—coronary artery disease	7.85e-07	4.56e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—coronary artery disease	7.82e-07	4.54e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	7.78e-07	4.52e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—coronary artery disease	7.78e-07	4.52e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6R—coronary artery disease	7.76e-07	4.51e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	7.74e-07	4.5e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—coronary artery disease	7.65e-07	4.44e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	7.61e-07	4.42e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—coronary artery disease	7.52e-07	4.37e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGT—coronary artery disease	7.52e-07	4.37e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	7.44e-07	4.32e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	7.42e-07	4.31e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—coronary artery disease	7.41e-07	4.31e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—coronary artery disease	7.38e-07	4.29e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—coronary artery disease	7.36e-07	4.28e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOA1—coronary artery disease	7.28e-07	4.23e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	7.27e-07	4.22e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	7.26e-07	4.22e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PIK3CA—coronary artery disease	7.24e-07	4.2e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGF2—coronary artery disease	7.19e-07	4.18e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—coronary artery disease	7.09e-07	4.12e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—coronary artery disease	7.06e-07	4.1e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGF2—coronary artery disease	7.03e-07	4.08e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—coronary artery disease	7.02e-07	4.08e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.97e-07	4.05e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—coronary artery disease	6.94e-07	4.03e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—coronary artery disease	6.93e-07	4.03e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JAK2—coronary artery disease	6.89e-07	4e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PIK3CA—coronary artery disease	6.89e-07	4e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCND1—coronary artery disease	6.87e-07	3.99e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—coronary artery disease	6.84e-07	3.97e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	6.75e-07	3.92e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JAK2—coronary artery disease	6.74e-07	3.91e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—coronary artery disease	6.73e-07	3.91e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	6.72e-07	3.9e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3CA—coronary artery disease	6.68e-07	3.88e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—coronary artery disease	6.67e-07	3.88e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	6.6e-07	3.84e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—coronary artery disease	6.47e-07	3.76e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—coronary artery disease	6.41e-07	3.73e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—coronary artery disease	6.41e-07	3.72e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—coronary artery disease	6.33e-07	3.68e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	6.29e-07	3.65e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	6.15e-07	3.57e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—coronary artery disease	6.1e-07	3.54e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	6.07e-07	3.53e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—coronary artery disease	6.02e-07	3.5e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—coronary artery disease	5.99e-07	3.48e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—coronary artery disease	5.98e-07	3.47e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—coronary artery disease	5.95e-07	3.46e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	5.94e-07	3.45e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—coronary artery disease	5.92e-07	3.44e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—coronary artery disease	5.91e-07	3.43e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—coronary artery disease	5.89e-07	3.42e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCND1—coronary artery disease	5.86e-07	3.4e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—coronary artery disease	5.85e-07	3.4e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—coronary artery disease	5.77e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCND1—coronary artery disease	5.73e-07	3.33e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—coronary artery disease	5.69e-07	3.3e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—coronary artery disease	5.62e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—coronary artery disease	5.56e-07	3.23e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—coronary artery disease	5.52e-07	3.21e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	5.52e-07	3.2e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—coronary artery disease	5.5e-07	3.19e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—coronary artery disease	5.49e-07	3.19e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—coronary artery disease	5.46e-07	3.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	5.4e-07	3.13e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	5.11e-07	2.97e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—coronary artery disease	5.05e-07	2.93e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	5e-07	2.9e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	4.69e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CA—coronary artery disease	4.68e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	4.6e-07	2.67e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	4.59e-07	2.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	4.5e-07	2.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—coronary artery disease	4.14e-07	2.41e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	3.99e-07	2.32e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	3.9e-07	2.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—coronary artery disease	3.82e-07	2.22e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—coronary artery disease	3.53e-07	2.05e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—coronary artery disease	3.46e-07	2.01e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—coronary artery disease	3.26e-07	1.89e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—coronary artery disease	3.19e-07	1.85e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CA—coronary artery disease	3.1e-07	1.8e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—coronary artery disease	2.54e-07	1.47e-06	CbGpPWpGaD
